Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Agape ATP Q3 2026: Revenue Falls to $4,798 in Three Months

Agape ATP Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 16, 2026, reporting continued net losses from continuing operations and a sharp decline in quarterly revenue.

Aakashdeep | 16 November 2026

FitLife Brands Posts $5.24M Net Income for Nine Months Ended Sept. 30, 2026

FitLife Brands, Inc. filed its quarterly report on Form 10-Q with the SEC on November 16, 2026, covering the three and nine months ended September 30, 2026, and reporting net income of $1.571 million for the quarter and $5.241 million for the nine-month period.

Nitish Kishor | 16 November 2026

CNS Pharmaceuticals Q3 2026: Net Loss $2.5M, Cash Rises to $17.2M

CNS Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 16, 2026, disclosing a net loss of $2.499 million for the third quarter and cash and cash equivalents of $17.212 million at …

Manish Choudhary | 16 November 2026

Westin Acquisition Corp Files Q1 FY2027 10-Q With $59.5M Trust

Westin Acquisition Corp filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 16, 2026, covering the quarter ended September 30, 2026, disclosing its financial position as a blank check company with approximately $59.4 million held in a trust account.

Nitish Kishor | 16 November 2026

CorMedix CEO Todisco Buys 80,000 Shares at $4.89

Joseph Todisco, Chief Executive Officer and Director of CorMedix Inc., filed a Form 4 on November 16, 2026, disclosing the open-market purchase of 80,000 shares of CorMedix common stock on November 13, 2026.

Vinay Lochav | 16 November 2026

Ballard Power Q3 2026: 20% Gross Margin After GeoPura Close

Ballard Power Systems filed its third-quarter 2026 earnings release on November 16, 2026, reporting total revenue of $22.5 million, a 20% gross margin, and updated full-year guidance following the close of its GeoPura acquisition.

Anjali Anand | 16 November 2026

DarioHealth Presents Biometric-to-PMPM Cost Savings Model at ISPOR Europe 2026

DarioHealth Corp. filed an 8-K press release on November 16, 2026, announcing the presentation of new health economics research at ISPOR Europe 2026 in Vienna, Austria, describing a methodology for estimating healthcare cost savings from digital chronic disease management programs without relying on medical …

Anjali Anand | 16 November 2026

Baxfendy Gets CHMP Positive Opinion for EU Hypertension

AstraZeneca PLC filed a Form 6-K on 16 November 2026 disclosing that its drug Baxfendy (baxdrostat) received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), recommending approval in the European Union for the treatment of adults …

Aditi Sarkar | 16 November 2026

Broadridge 2026 Survey: AI Boosts Efficiency at 79% of Firms

Broadridge Financial Solutions and the Money Management Institute released results of their fourth annual Investment Advisory Pulse Survey on November 16, 2026, covering AI adoption, product trends, and competitive pressures across 140 member firms.

Aakashdeep | 16 November 2026

22nd Century Group S-8 Filed After 1-for-58 Reverse Split

22nd Century Group, Inc. filed a Form S-8 registration statement with the SEC on November 16, 2026, to register additional shares under its Amended and Restated 2021 Omnibus Incentive Plan following a 1-for-58 reverse stock split completed in November 2026.

Manish Choudhary | 16 November 2026
Support

Hi! How can we help you today?

Loading…